KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Vertex Pharmaceuticals' Profit After Tax rose 358.71% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 86596.5%. This contributed to the annual value of -$535.6 million for FY2024, which is 11479.72% down from last year.
  • Vertex Pharmaceuticals' Profit After Tax amounted to $1.1 billion in Q3 2025, which was up 358.71% from $1.0 billion recorded in Q2 2025.
  • Vertex Pharmaceuticals' Profit After Tax's 5-year high stood at $1.1 billion during Q1 2024, with a 5-year trough of -$3.6 billion in Q2 2024.
  • For the 5-year period, Vertex Pharmaceuticals' Profit After Tax averaged around $605.8 million, with its median value being $851.9 million (2021).
  • Per our database at Business Quant, Vertex Pharmaceuticals' Profit After Tax soared by 110970.15% in 2022 and then tumbled by 49244.29% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Profit After Tax (Quarter) stood at $770.1 million in 2021, then grew by 6.34% to $818.9 million in 2022, then grew by 18.31% to $968.8 million in 2023, then dropped by 5.76% to $913.0 million in 2024, then grew by 18.61% to $1.1 billion in 2025.
  • Its Profit After Tax was $1.1 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $646.3 million in Q1 2025.